HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

3,9-bis((ethylthio)methyl)-K-252a

RN given for (9S-(9alpha,10beta,12alpha))-isomer; mixed lineage kinase inhibitor, neuroprotective agent, and neurotrophic agent derived from K-252a; structure in first source
Also Known As:
3,9-bis(EtSM)-K-252a; CEP 1347; CEP-1347; CEP1347; KT 7515; KT-7515; KT7515
Networked: 31 relevant articles (2 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shoulson, Ira: 4 articles (08/2011 - 12/2009)
2. Oakes, David: 3 articles (08/2011 - 12/2009)
3. Lang, Anthony E: 3 articles (03/2011 - 12/2009)
4. Maroney, Anna C: 3 articles (04/2004 - 01/2002)
5. Parkinson Study Group PRECEPT Investigators: 2 articles (08/2011 - 10/2007)
6. Parkinson Study Group DATATOP and PRECEPT investigators: 2 articles (03/2011 - 12/2009)
7. Marras, Connie: 2 articles (03/2011 - 12/2009)
8. Rudolph, Alice: 2 articles (03/2011 - 09/2010)
9. Schwid, Steven R: 2 articles (09/2010 - 12/2009)
10. Hyson, Christopher: 2 articles (09/2010 - 12/2009)

Related Diseases

1. Ischemia
2. Anoxia (Hypoxia)
3. Pancreatitis
4. Parkinson Disease (Parkinson's Disease)
5. Parkinsonian Disorders (Parkinsonism)

Related Drugs and Biologics

1. Caerulein (Ceruletide)
2. Selegiline (E250)
3. Phosphotransferases (Kinase)
4. Brain-Derived Neurotrophic Factor (BDNF)
5. Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
6. Uric Acid (Urate)
7. 3,9-bis((ethylthio)methyl)-K-252a
8. JNK Mitogen-Activated Protein Kinases
9. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
10. SB 203580

Related Therapies and Procedures

1. Intraperitoneal Injections